TIDMBIOG 
 
The Biotech Growth Trust PLC (the "Company") 
 
Compliance with Market Abuse Regulation 
 
11 October 2023 
 
The Company confirms that: 
 
a)         all inside information which the Directors and Company may have had 
has been notified to a Regulated Information Service ("RIS"); 
 
b)         the Company's net asset value per share is calculated and announced 
through a RIS on a daily basis; and 
 
c)         the Company does not believe that there will be a material difference 
between the net asset value per share as at close of business on Friday, 29 
September 2023, which was announced on Monday, 2 October 2023, and the financial 
information to be published in the announcement of its results for the half year 
ended 30 September 2023. 
 
The Company is, therefore, not prohibited from dealing in its own securities 
during the closed period, as defined by the Market Abuse Regulation, which will 
end on the date of the publication of its results for the half year ended 30 
September 2023, expected to be on or after 9 November 2023. 
 
-ENDS- 
 
For further information please contact: 
 
Katherine Manson         Frostrow Capital LLP     020 3709 8734 
 
 
This information was brought to you by Cision http://news.cision.com 
 
 
END

(END) Dow Jones Newswires

October 11, 2023 04:54 ET (08:54 GMT)

Biotech Growth (LSE:BIOG)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Biotech Growth.
Biotech Growth (LSE:BIOG)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Biotech Growth.